Clear Guide Medical Receives
 $200,000 Maryland Biotechnology Development Award

Clear Guide Medical received a $200,000 Maryland Biotechnology Development Award to accelerate the commercialization of its first clinical product, the Clear Guide ONE™.  The Clear Guide ONE is a radical innovation in the field of image guidance because of its simplicity and ease of use. The system can be added to any ultrasound probe and system, and it is pre-calibrated, unobtrusive and "always on" so that it is ready to use as soon as the touchscreen is turned on – there is no lengthy set-up time or change to the workflow.  "With this award we hope to be selling the Clear Guide ONE by August of this year," says CEO Dorothee Heisenberg.  "Although we can't reliably predict when the FDA will clear the Clear Guide ONE, this award helps us put in place all the necessary manufacturing and quality system components so that we will be able to sell it as soon as it is cleared."  Clear Guide Medical already sells the non-clinical training system, the Clear Guide EDU™ which trains physicians in needle-based procedures such as anesthesia, fluid drainage and biopsy with the same quality components as the Clear Guide ONE.  The company is currently developing the Clear Guide VET™ which uses the same technology for veterinarians to guide needle-based procedures in animals.

ABOUT CLEAR GUIDE MEDICAL
Clear Guide Medical is a privately-held company based in Baltimore, MD which develops innovative technologies to provide advanced image-guidance for needle-based interventions and diagnostics. The company won the Maryland Incubator Company of the Year Award in the Life Sciences/Medical Device category and was also a finalist in Maryland's 2013 and 2012 Innovation, Corporate Excellence and Entrepreneurship (ICE) Awards, as well as a national top 10 University Startup in 2012. The company has received over $2.2 million in grants and awards and is seeking private investment. Clear Guide Medical is also a Qualified Maryland Biotechnology Company and qualified investments may receive the investment tax credit for up to $250,000 (http://www.choosemaryland.org/businessresources/pages/biotechnologyinvestmenttaxcredit.aspx; note that non-Maryland investors may participate and receive cash if they have no Maryland tax obligations). Contact investment@clearguidemedical.com to learn how you can share in the growth of the company.

ABOUT THE MARYLAND BIOTECHNOLOGY DEVELOPMENT AWARD
Since its inception in 2010, the BioMaryland Center has awarded more than $6 million in Biotechnology Development Awards to 32 Maryland life science companies.  These are a key component of Governor O’Malley’s Bio 2020 initiative. The BioMaryland Center is part of the State’s business and economic development agency, the Maryland Department of Business and Economic Development (DBED).

ABOUT BIOMARYLAND CENTER
The BioMaryland Center, an office within Maryland's Department of Business and Economic Development, connects life sciences companies, academic and federal researchers with each other and with potential capital sources, partners, clients, and other resources. Center staff provide information regarding funding and other resources, business plan feedback, access to market research, advocacy, and other industry support. The BioMaryland Center also promotes the state's life sciences industry domestically and abroad. For more information regarding the Center and the Biotechnology Development awards program, visit www.Bio.Maryland.gov.

ABOUT DBED
The Maryland Department of Business and Economic Development stimulates private investment and creates jobs by attracting new businesses, encouraging the expansion and retention of existing companies, and providing workforce training and financial assistance to Maryland companies. The Department promotes the State's many economic advantages and markets local products and services at home and abroad to spur economic development and international investment, trade and tourism. For more information, visit www.ChooseMaryland.org.